Total 2012 $53,211,000, 8% YoY growth (Excellent YoY growth)
I would guess that the BioGlue cost center will generate roughly $19 million EDITDA during 2013. Assuming that CRY can continue to slowly grow this market, this product line is and will remain EXTREMELY profitable. However, IF someone would ever aggressively and effectively attack this market, it would be a serious problem for CRY. Right now though, I don’t see this type of threat on CRY’s horizon.
BioFoam sales seem to be included in the above numbers.
Conclusion: Draw your own conclusions. You Amigo have to sort things out for yourself, as you are responsible for doing your own due diligence.